PTX3 and adrenal gland neoplasm: Among the pathogenic elements of these cardio-metabolic elements, new emergent biomarkers are mandatory, as recently proven by a higher level of pentraxin 3, an acute-phase glycoprotein that has been involved in this particular instance of adrenal tumour-related cardio-metabolic traits [161].